bpc-157 clinical trials dosage BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157: Benefits & Dosage Guide
Description
The Regenexx approach offers a non-surgical alternative

STAGE 2 5mg strength This is the therapeutic strength dosing that requires less volume injected 3

Ideal For: Complementing aesthetic and skincare routines Key Ingredients: Biotin, Glutathione, and Alpha-Lipoic Acid

This is a convenient option for busy professionals, frequent travelers or anyone who prefers on site care
